Syantra Inc.

Private

CalgaryHealthcare & Life Scienceshttps://www.syantra.com/

Last Round

Series A

Extension

Sep 11, 2024

Total Funding Raised

$9.04M

Company Overview

Syantra Inc. is a biotechnology company that develops a blood-based platform for the early detection and diagnosis of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Medical Devices

Business Model

B2B2C

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

liquid biopsycancer blood testearly cancer detectionbreast cancer detectionAI diagnosticsprecision medicineRNA biomarkersgene expression analysiscancer diagnosticslaboratory developed testLDTimmune response detectionmRNA analysisqPCR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Syantra Inc. Comps

Public and private peers based on sector, stage, and business model.

Syantra Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Syantra Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Sep 11, 2024
Series A	Jan 20, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Kristina Rinker

Chief Scientific Officer And Founder

Founding Team

Rob Lozuk

Chief Executive Officer, President, Secretary And Member Board Of Directors

Executive Team

Robert Shepherd

Chief Operating Officer

Executive Team

Syantra Inc. Investors

Notable investors and investment history

Syantra Inc. investors
Investor	Rounds
Yaletown Partners	Seed, Series A
The51	Seed, Series A
Canaccord Genuity	Series A Extension
Plug and Play Alberta	Series A
Innovate Calgary	Seed, Series A
Thin Air Labs	Seed, Series A
MENA Moonshots	Seed, Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 6, 2025
Monthly visitors increased 58% MoM.
Nov 6, 2025
Monthly visitors grew 294% MoM, reaching 1.4K.

View all signals

Syantra Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Syantra Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Syantra Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCalgary

Employee Range16

Year Founded2016

Last FundingSep 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.